Thus far, liver, intestine, heart and placenta have been shown to secrete apolipoprotein(apo)Bcontaining lipoproteins. In the present study we first investigated lipoproteins in human follicular fluid (FF), surrounding developing oocytes within the ovary, as well as in corresponding plasma samples (n=12). HDL cholesterol (HDL-C) within FF correlated well with plasma HDL-C (r=0.80, p<0.01), while VLDL-C did not, indicating that VLDL in FF might originate directly from the granulosa cells producing FF. Primary human granulosa cells expressed apoB, microsomal triglyceride transfer protein and apoE, however, not the apoB-editing enzyme apobec-1. Using 3 H-leucine we show that granulosa cells secrete apoB100-containing lipoproteins and that secretion can be stimulated by adding oleate to the medium (+83%). With electron microscopy apoB-containing lipoproteins within the secretory pathway of human granulosa cells were directly visualized. Finally, we found a positive relationship between apoB levels in follicular fluid and improved fertility parameters in a population of 27 women undergoing in vitro fertilization. This study demonstrates that human granulosa cells assemble and secrete apoB100-containing lipoproteins, thereby identifying a novel cell type equipped with these properties. These results might have important implications for female infertility phenotypes as well as for the development of drugs targeting the VLDL production pathway.
Introduction
The ability to assemble and secrete apolipoprotein(apo) B-containing lipoproteins has long been known for enterocytes as well as hepatocytes (1, 2) . These cells use chylomicrons to secrete resorbed cholesterol and triglycerides (TG) in the case of enterocytes (3) , and very low density lipoproteins (VLDL) to export endogenously synthesized or internalized cholesterol and TG in the case of hepatocytes (4, 5) . ApoB-containing lipoproteins are also secreted by the human placenta supposedly to transfer lipids from the maternal circulation to the fetus (6) .
Recently, another cell type in the body has been recognized to be capable of producing apoBcontaining lipoproteins, namely cardiomyocytes (7) . In the heart, VLDL secretion is thought to represent a means of protecting the organ against toxicity associated with TG accumulation (8, 9) . In contrast, other peripheral cells utilize apoB-containing lipoproteins to meet their supply with triglycerides and cholesterol.
Developing oocytes within ovarian follicles grow rapidly and require supply with energy and cholesterol (10) . Oocytes are surrounded by follicular fluid (FF) that in contrast to human plasma mainly contains high density lipoprotein (HDL) cholesterol, the smallest lipoprotein subclass (11, 12) . Although expression of the LDL receptor as well as of LDL receptor-related protein (LRP) 4 has been reported for mammalian oocytes (13, 14) , most research at present has been focussed on HDL within FF. Granulosa cells, the major estrogen producing cell type of the follicle, line the follicle and are shielded against the blood compartment by a basal membrane (15) (16) (17) . While HDL are thought to enter the FF by diffusion (11) , apoB-containing lipoproteins, which are considerably larger in size, are not expected to do so. However, given the presence of receptors for apoB-containing lipoproteins on oocytes, we hypothesized that granulosa cells 4 might display an intrinsic ability to assemble and secrete apoB-containing lipoproteins.
Therefore, we tested this hypothesis in the present study. Our results provide evidence that human granulosa cells represent a novel cell type that is capable of assembly and secretion of apoB-containing lipoproteins.
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Generation of human follicular fluid and isolation of granulosa cells.
Human follicular fluid was obtained from women who were undergoing in vitro fertilization (Center of Sterility, CHU Dijon or Klinik fuer Frauenheilkunde und Geburtshilfe, Luebeck) and were following a follicle-stimulation regimen including the injection of 10,000 IU of human chorionic gonadotrophin 36 h before transvaginal follicle puncture under ultrasound guidance exactly as previously described (18, 19). After oocyte isolation, follicular fluids were obtained, centrifuged for 5 min at 1500 rpm and stored at -80°C until analysis. Granulosa cells were then isolated and cultured in DMEM medium supplemented with 10% FBS and antibiotics as previously published (19). At the same time a fasting peripheral venous blood sample was obtained from the patients and plasma was stored frozen at -80°C. All patients had given informed consent and the protocol was approved by the respective responsible local ethics committees.
Lipid and Lipoprotein Analysis.
To assess the cholesterol distribution over the different lipoprotein subclasses, plasma as well as follicular fluid samples were subjected to fast protein liquid chromatography (FPLC) gel filtration using a superose 6 column (GE Healthcare, Uppsala, Sweden) as described (20). Total cholesterol levels were enzymatically measured within individual fractions using commercially available reagents (Wako Pure Chemical Industries, Neuss, Germany). To correlate plasma and follicular fluid levels of lipoproteins, the respective values obtained for all fractions of a given subclass (VLDL, LDL, HDL) were added. 
Analysis of gene expression by real-time quantitative PCR.
Total RNA from granulosa cells, HepG2 cells (obtained from LGC Standards, Middlesex, UK) and human livers (samples from healthy donor livers intended for liver transplantation but not used due to technical reasons, provided by Dr. Matthias Bahr, Dept. of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Germany) was isolated using trizol (Invitrogen), and quantified with a NanoDrop ND-100 UV-Vis spectrophotometer. cDNA synthesis was performed from 1 μg of total RNA using reagents from Applied Biosystems (Darmstadt, Germany). Real-time quantitative PCR was carried out on an ABI-Prism 7700 (Applied Biosystems) sequence detector with the default settings (21). PCR primers and fluorogenic probes were designed with the Primer Express Software (Applied Biosystems) and synthesized by Eurogentec (Seraing, Belgium). mRNA expression levels presented were calculated relative to the average of the housekeeping gene cyclophilin and further normalized to the relative expression level determined in granulosa cells.
In vitro VLDL production experiments and Western blot for apoB.
Human primary granulosa cells cultured for 3 days were pre-incubated for 20h in serum- was determined. An embryo was considered a top quality embryo if there were four or five blastomeres on day 2 with <20% of fragments and the total absence of multinucleated blastomeres (23). All ETs were performed 2 days after oocyte retrieval using Frydman catheters (CCD Laboratories, Paris, France). A clinical pregnancy was defined as the observation of a gestational sac on ultrasound scanning between 6 and 7 weeks after embryo transfer.
In parallel with IFV-ET, FF were analyzed for apoB content. By the day of oocyte retrieval, FF aliquots were collected and examined by an embryologist to detect and remove cumulus-oocyte complexes, centrifuged at 3000 x g for 15 minutes to eliminate cellular elements and supernatants were stored at -80°C before analysis. Apolipoprotein B concentration in FF was determined by an immunoturbidimetric method (24) using a commercial kit with a goat anti- 
Statistical analysis.
Statistical analyses were performed using the statistical package for social sciences (SPSS; SPSS Inc., Chicago, IL). Data are presented as means ± SEM unless otherwise indicated. of the cholesterol is contained within the HDL fraction, indicating that the major cholesterol carrier within FF is HDL ( Figure 1A ). However, a small but consistently present VLDL peak was discernible in all FPLC profiles performed on FF ( Figure 1A ). In contrast, in plasma 61% of the cholesterol is found within apoB-containing lipoproteins and on average only 39% within HDL ( Figure 1A ). Relating plasma lipoprotein cholesterol to FF cholesterol levels, plasma contains 5.6-fold more VLDL, 15.4-fold more LDL and 1.8-fold more HDL cholesterol compared with FF. Interestingly, HDL cholesterol levels in plasma were correlated with FF HDL cholesterol (r=0.80, p<0.01, Figure 1B ) consistent with diffusion being the conceivable mechanism of entry for HDL lipoproteins into FF (11, 25) . On the other hand, VLDL cholesterol levels in plasma and FF were not correlated (r=0.05, n.s., Figure 1C ). These data demonstrate that VLDL is present in human follicular fluid and indicate that, in contrast to HDL, FF-VLDL might not be derived directly from plasma.
Human granulosa cells express MTP and apoB.
To further test the hypothesis that FF-VLDL are assembled and secreted on site, we first Human granulosa cells secrete apoB100-containing lipoproteins, which is stimulated by the addition of oleic acid.
Next we explored, if the expression of the relevant genes for assembly and secretion of apoB-containing lipoproteins in granulosa cells also translates into actual VLDL production.
Therefore, we initially performed Western blots on cell culture supernantants of granulosa cells grown in FBS-free medium. As shown in Figure 3A , an apoB100 band could be detected, while consistent with the absent expression of apobec1, no immunoreactive apoB48 was found.
Interestingly, the intensity of the apoB band appeared to be increased following incubation of the Subsequently, a pulse-chase experiment was performed using a pulse of 3 H-leucine for 25 min on primary human granulosa cells pre-incubated either in the absence or the presence of oleate. After a chase for 1h, supernatants were collected and counts within apoB-containing lipoproteins produced were assessed. Using this approach, we could demonstrate that significant amounts of tracer are incorporated into apoB secreted by granulosa cells and that the addition of oleate resulted in a 83% increase of apoB protein secretion from these cells ( Figure 3B ).
VLDL-like particles can be directly visualized by electron microscopy within primary human granulosa cells.
In addition to demonstrating VLDL production by granulosa cells, we also investigated these cells by electron microscopy. Interestingly, small lipid-staining particles with a diameter ranging from 50 to 150nm, in terms of appearance consistent with the presence of apoBcontaining lipoproteins in the secretory pathway (33), were detected within the Golgi apparatus of granulosa cells (Figure A-D) . These results demonstrate that apoB-containing lipoproteins can be directly visualized by electron microscopy within granulosa cells, providing further evidence that these cells assemble and secrete VLDL. Patients were subsequently divided into two groups according to the median apoB level in FF, with values ≤ 13.6 mg/L and > 13.6 mg/L in the 'low apoB' group and in the 'high apoB' group, respectively (Table 1) . Age distribution, body mass index and the IVF to ICSI ratio were not statistically different between groups. When apoB stratification was applied to the whole population (n=27), the number of grade 4 embryos was significantly higher in 'high apoB' patients compared with 'low apoB' patients (2.8 ± 2.2 vs. 1.6 ± 2.7, respectively; P< 0.05) and this was accompanied with a higher pregnancy rate in the 'high apoB' group compared with the 'low apoB' group (69.1% vs. 23.1%, respectively; P < 0.05) ( Table 1 , left). Since the population studied includes patients with direct ovarian disorders that might introduce confounding factors to follicular function and oocyte quality, the same stratification was performed after exclusion of patients with polycystic ovary syndrome, ovarian endometriosis, ovulatory dysfunction or those who underwent ovarian surgery. Again, in the remaining population (n=18), high apoB levels in FF were associated with a higher number of grade 4 embryos (3.6 ± 1.5 vs. 0.6 ± 0.9 in the 'low apoB' group; P < 0.05), a higher number of top quality embryos (4.0 ± 1.6 vs. 1.2 ± 1.3 in the 'low apoB' group; P < 0.05) and also a strikingly higher clinical pregancy rate (60.0% vs. 0.0% in the 'low apoB' group; P < 0.05, Table 1 , right). These data suggest that the concentration of apoB present in FF might predict oocyte quality for the generation of viable embryos and further successful implantation and pregnancy.
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Discussion
The results of this study demonstrate that human granulosa cells assemble and secrete apoB100-containing lipoproteins. Thereby, granulosa cells represent a novel cell type with these properties in addition to enterocytes (3), hepatocytes (1, 2), cardiomyocytes (7), placenta (herein presumably trophoblasts) (6) and, at least in the chicken, the kidney (35) . Thus far, secretion of apoB-containing lipoproteins has been shown to serve two different purposes that might, however, be related as in the case of hepatocytes: (i) supply distant cells via the blood stream with triglycerides and cholesterol, (ii) prevent cellular stress and toxicity associated with triglyceride overload.
Within a growing follicle in the ovary, the oocyte is surrounded by concentric layers of cells and tissue, which are from the periphery inwards: (i) theca externa, (ii) theca interna, (iii) basal membrane, (iv) granulosa cells (17). The oocyte has as a rapidly growing cell a considerable demand for energy as well as cholesterol (10) . Although most earlier studies detected only HDL within follicular fluid (11, 36) , there are single reports on the presence of VLDL in older literature in a variable percentage of subjects investigated (12, 37) . A very recent study reported apoB to consistently be detectable within follicular fluid in agreement with our results (38) . However, the possibility of granulosa cells secreting apoB-containing lipoproteins has not been investigated previously. Although the precise role of apoB-containing lipoprotein secretion by granulosa cells is presently unclear, it appears conceivable that apoB-containing lipoproteins might have a nourishing function, that the TG-poor HDL lipoproteins are not able to fulfil properly. In favour of such a theory is on the one hand the expression of receptors from the LDLR family on oocytes (13, 14) and on the other the correlation of FF-apoB levels to the outcome of IVF-ET. Since VLDL also contain lipophilic components such as vitamins, e.g.
vitamin E, (39) or steroids (40) , delivery of these components to oocytes might also be a function of apolipoprotein B-containing lipoprotein secretion by granulosa cells. However, it can not be excluded that granulosa cells utilize the secretion of apoB-containing lipoproteins to prevent TG accumulation, since they might be sensitive towards metabolic stress.
An interesting question to explore is the relevance of reduced or increased apoBcontaining lipoprotein production by granulosa cells for reproductive physiology. Thus far in humans, to our knowledge no association between genetic variation within the apoB locus and female infertility has been published. In addition, there are also no patients reported completely lacking apoB. Consistent with this notion is the observation that homozygous apoB knockout mice die in utero, due to severe neurodevelopmental abnormalities (41) (42) (43) . In female heterozygous mice no apparent infertility has been described, but male heterozygous apoB knockout mice display reduced fertility, which has been directly related to the expression of apoB within the male reproductive tract (43, 44 ). An initial study indicated that at least the insertion/deletion polymorphism of the apoB gene might be related to male infertility in humans (45) . However, apoB expression has not been demonstrated thus far in the female reproductive tract. Our data on the outcome of IVF-ET suggest that an association between reduced apoB expression and decreased fertility might also exist in female human patients, that has thus far escaped recognition. In accordance with this hypothesis, we show here for the first time in humans a positive relationship between the apoB levels in follicular fluid and fertility parameters as reflected by embryo quality and pregnancy rate in a small cohort of women undergoing IVF-ET. Thereby our observations support a physiological relevance of apoB expression by follicular cells during oocyte maturation.
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The second essential gene for apoB-containing lipoprotein production is MTP (1). While homozygous MTP knockout mice die in utero, no obvious female fertility phenotype has been published in heterozygous knockouts (46) . Also reports on fertility are lacking for human patients suffering from abetalipoproteinemia, a rare autosomal recessive disease with the complete absence of MTP due to genetic mutations (47) . However, conditional knockout mice have been generated for MTP (48, 49) . Therefore the pathophysiological consequences of genetic ablation of MTP and thereby production of apoB-containing lipoproteins specifically in granulosa cells are testable at least in the mouse model. We would also recommend to consider investigating whether there is an association between genetic variations within apoB and MTP loci and female infertility in human patients. In addition, it would be relevant to learn about the effects of MTP Tables   Table 1: Patient characteristics, embryo quality and fertility in groups with low and high apoB concentration in follicular fluid.
All patients Patients without direct ovarian disorders
ApoB (mg/L) ApoB (mg/L) Low (≤ 13.6) (n = 14)
High (> 13.6) (n = 13) P values Low (≤ 13.6) (n = 9)
High (> 13.6) (n = 9) 
